New ArcheMedX Report “COVID-19’s Impact on Virtual Tech in Clinical Trials” Reveals Changing Priorities for Sponsors, CROs in a Remote World
If you’re going to start a clinical trial in the post-COVID area, a virtual investigator meeting needs to be in your plans. Here’s how to do it.
Interview: Start-Up Phase is a Prime Target for Virtual Activities in Clinical Trials, So Let’s Adapt
Before 2020 “virtual clinical trials” was just a buzzword. Now we’re forced to adapt. But what challenges – and opportunities – are ahead?
As COVID-19 continues to impact us, principle investigator meetings are off the table. Or are they? Yes, you can pull off an effective, virtual investigator meeting for your clinical trial. Here’s how to make sure you do.
Implementing clinical trial readiness enables you to confidently predict who will succeed in conducting your clinical trial – and who needs more preparation.
You’re using the clinical trial site selection checklist you’ve always used, but you’re still struggling with the same delays, site problems, and retraining you see in every trial. Why? It’s time to adjust the way you measure your sites for selection.